Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children

NNT Minh, K Edelman, Q He, MK Viljanen, H Arvilommi… - Vaccine, 1998 - Elsevier
235 healthy 10–12 years old school children were randomly immunized with either a
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …

Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents

NNT Minh, Q He, A Ramalho, A Kaufhold… - …, 1999 - publications.aap.org
Objective. To evaluate the immunogenicity and reactogenicity of an acellular pertussis
vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered …

Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age

DI BERNSTEIN, VE SMITH, GM SCHIFF… - The Pediatric …, 1993 - journals.lww.com
The safety and immunogenicity of a booster dose of a new acellular pertussis component
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children

ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …

[PDF][PDF] Study of pertussis vaccines in infants: Comparison of response to acellular pertussis DTP vaccines containing 25 μg of FHA and either 25 or 8 μg of

H Vanura, M Just, F Ambrosch, RM Berger, H Bogaerts… - Vaccine, 1994 - academia.edu
Clinical and serological responses of infants to primary vaccination with diphtheriatetanus-
acellular pertussis (DTPa) vaccines containing 25# g of filamentous haemagglutinin (FHA) …

Safety and immunogenicity of an acellular pertussis vaccine booster in 15-to 20-month-old children previously immunized with acellular or whole-cell pertussis …

ME Pichichero, AB Francis, SM Marsocci, JL Green… - …, 1993 - publications.aap.org
The objective of this study was to evaluate reactogenicity and immunogenicity of the recently
US-licensed Connaught/BIKEN (C/B) acellular DTP (ADTP) vaccine as a booster for children …

Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children

ME PICHICHERO, JL GREEN… - The Pediatric …, 1994 - journals.lww.com
An acellular pertussis vaccine (DTaP) containing pertussis toxoid, filamentous
hemagglutinin and the 69-kDa outer membrane protein (pertactin) was compared with …

Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine

OO Fadugba, L Wang, Q Chen… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Given the resurgence of pertussis despite high rates of vaccination with the diphtheria-
tetanus-acellular pertussis (DTaP) vaccine, a better understanding of vaccine-induced …

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children

ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines

A Cassone, CM Ausiello, F Urbani… - … of pediatrics & …, 1997 - jamanetwork.com
Objective: To examine induction and persistence of cell-mediated immunity (CMI) and
antibody responses toBordetella pertussisantigens in infants receiving antipertussis …